Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.474 SEK | 0.00% |
|
-1.99% | -15.04% |
05-08 | Sprint Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-14 | Sprint Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
9.74M | - | - | - | |||
122B | ||||||
115B | ||||||
26.64B | - | |||||
19.91B | - | |||||
16.32B |